Nearly half of U.S. coronavirus patients in intensive care are under 65, CDC reports
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
You are now subscribed
Your newsletter sign-up was successful
Older Americans are still at greater risk of death from the new COVID-19 coronavirus, but 38 percent of the U.S. patients known to have been hospitalized for COVID-19 were between age 20 and 54, and nearly half of those admitted to the intensive care unit were adults under 65, the Centers for Disease Control and Prevention reported Wednesday. The report looked at 508 of the first 2,449 coronavirus patients in the U.S. The high rate of hospitalization for younger adults matches the statistics reported from France and Italy.
The report showed that adults of all ages are at risk of getting sick from the coronavirus — of the 2,449 patients examined, 6 percent were 85 and older, 25 percent were 65 to 84, 29 percent were 20 to 44, and 5 percent were 19 and younger, the CDC said. People 20 to 44 — the millennial generation — accounted for 20 percent of those hospitalized and 12 percent of ICU patients.
"I think everyone should be paying attention to this," Columbia University epidemiologist Stephen S. Morse tells The New York Times. "It's not just going to be the elderly. There will be people age 20 and up. They do have to be careful, even if they think that they're young and healthy." And it's not just the health of younger people that has experts worried, adds Dr. Christopher Carlsten, the head of respiratory medicine at the University of British Columbia. "If that many younger people are being hospitalized, that means that there are a lot of young people in the community that are walking around with the infection," putting older and sicker people at risk.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
What is the endgame in the DHS shutdown?Today’s Big Question Democrats want to rein in ICE’s immigration crackdown
-
‘Poor time management isn’t just an inconvenience’Instant Opinion Opinion, comment and editorials of the day
-
Bad Bunny’s Super Bowl: A win for unityFeature The global superstar's halftime show was a celebration for everyone to enjoy
-
A Nipah virus outbreak in India has brought back Covid-era surveillanceUnder the radar The disease can spread through animals and humans
-
Trump HHS slashes advised child vaccinationsSpeed Read In a widely condemned move, the CDC will now recommend that children get vaccinated against 11 communicable diseases, not 17
-
Covid-19 mRNA vaccines could help fight cancerUnder the radar They boost the immune system
-
FDA OKs generic abortion pill, riling the rightSpeed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
-
The new Stratus Covid strain – and why it’s on the riseThe Explainer ‘No evidence’ new variant is more dangerous or that vaccines won’t work against it, say UK health experts
-
RFK Jr. vaccine panel advises restricting MMRV shotSpeed Read The committee voted to restrict access to a childhood vaccine against chickenpox
-
Texas declares end to measles outbreakSpeed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agencySpeed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
